org 9935 has been researched along with albuterol in 1 studies
| Studies (org 9935) | Trials (org 9935) | Recent Studies (post-2010) (org 9935) | Studies (albuterol) | Trials (albuterol) | Recent Studies (post-2010) (albuterol) |
|---|---|---|---|---|---|
| 15 | 0 | 1 | 10,108 | 3,059 | 2,058 |
| Protein | Taxonomy | org 9935 (IC50) | albuterol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 1.2618 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blease, K; Burke-Gaffney, A; Hellewell, PG | 1 |
1 other study(ies) available for org 9935 and albuterol
| Article | Year |
|---|---|
Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Albuterol; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Endothelium, Vascular; Eosinophils; Humans; Lung; Neutrophils; Phosphodiesterase Inhibitors; Pyrrolidinones; Rolipram; Thiophenes; Tumor Necrosis Factor-alpha | 1998 |